These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia]. Okabe M Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066 [TBL] [Abstract][Full Text] [Related]
5. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia. Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117 [TBL] [Abstract][Full Text] [Related]
6. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Ahuja HG; Jat PS; Foti A; Bar-Eli M; Cline MJ Blood; 1991 Dec; 78(12):3259-68. PubMed ID: 1683797 [TBL] [Abstract][Full Text] [Related]
7. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Ahuja H; Bar-Eli M; Advani SH; Benchimol S; Cline MJ Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6783-7. PubMed ID: 2771957 [TBL] [Abstract][Full Text] [Related]
8. Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis. Foti A; Ahuja HG; Allen SL; Koduru P; Schuster MW; Schulman P; Bar-Eli M; Cline MJ Blood; 1991 Jun; 77(11):2441-4. PubMed ID: 2039825 [TBL] [Abstract][Full Text] [Related]
10. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304 [TBL] [Abstract][Full Text] [Related]
11. P53 gene mutations in chronic myelogenous leukemia medullary and extramedullary blast crisis. Marasca R; Luppi M; Barozzi P; Ferrari MG; Morselli M; Torelli G Leuk Lymphoma; 1996 Dec; 24(1-2):175-82. PubMed ID: 9049974 [TBL] [Abstract][Full Text] [Related]
12. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia. Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728 [TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a new Ph1-positive chronic myeloid leukemia cell line MC3 with trilineage phenotype and an altered p53 gene. Okabe M; Kunieda Y; Nakane S; Kurosawa M; Itaya T; Vogler WR; Shoji M; Miyazaki T Leuk Lymphoma; 1995 Feb; 16(5-6):493-503. PubMed ID: 7787756 [TBL] [Abstract][Full Text] [Related]
14. Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML. Guerrasio A; Martinelli G; Ambrosetti A; Falda M; Paolino F; Rege-Cambrin G; Rosso C; Pignatti PF; Gasparini P; Perona G Haematologica; 1991; 76(2):126-30. PubMed ID: 1937170 [TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. Neubauer A; He M; Schmidt CA; Huhn D; Liu ET Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238 [TBL] [Abstract][Full Text] [Related]
16. Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis. Guinn BA; Smith M; Padua RA; Burnett A; Mills K Leuk Res; 1995 Aug; 19(8):519-25. PubMed ID: 7658697 [TBL] [Abstract][Full Text] [Related]
17. p53 gene mutations with chromosome 17 abnormalities in chronic myelogenous leukemia blast crisis patients persist in long-term cell lines but may be acquired in acute myeloid leukemia cells in vitro. Sen S; Zhou H; Andersson BS; Cork A; Freireich EJ; Stass SA Cancer Genet Cytogenet; 1995 Jul; 82(1):35-40. PubMed ID: 7627932 [TBL] [Abstract][Full Text] [Related]
18. CML: mechanisms of disease initiation and progression. Wetzler M; Talpaz M; Estrov Z; Kurzrock R Leuk Lymphoma; 1993; 11 Suppl 1():47-50. PubMed ID: 8251916 [TBL] [Abstract][Full Text] [Related]
19. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients. Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454 [TBL] [Abstract][Full Text] [Related]
20. Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression. Wetzler M; Kurzrock R; Lowe DG; Kantarjian H; Gutterman JU; Talpaz M Blood; 1991 Nov; 78(9):2400-6. PubMed ID: 1932751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]